Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Concert Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Concert Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Concert Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Concert Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Concert Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Concert Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Concert Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Concert Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Concert Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Concert Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Concert Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Concert Pharmaceuticals, Inc. Snapshot 5 Concert Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Concert Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Concert Pharmaceuticals, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Out-Licensed Products 11 Out-Licensed Products/Combination Treatment Modalities 12 Concert Pharmaceuticals, Inc. - Pipeline Products Glance 13 Concert Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Concert Pharmaceuticals, Inc. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Concert Pharmaceuticals, Inc. - Drug Profiles 17 CTP-499 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 CTP-354 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 C-10068 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 CTP-221 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 D-Ivacaftor 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 D-Praziquantel 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 C-10291 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Concert Pharmaceuticals, Inc. - Pipeline Analysis 25 Concert Pharmaceuticals, Inc. - Pipeline Products by Target 25 Concert Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 26 Concert Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 27 Concert Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 28 Concert Pharmaceuticals, Inc. - Recent Pipeline Updates 29 Concert Pharmaceuticals, Inc. - Dormant Projects 33 Concert Pharmaceuticals, Inc. - Locations And Subsidiaries 34 Head Office 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 36 Disclaimer 36
List of Tables Concert Pharmaceuticals, Inc., Key Information 5 Concert Pharmaceuticals, Inc., Key Facts 5 Concert Pharmaceuticals, Inc. - Pipeline by Indication, 2014 8 Concert Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9 Concert Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10 Concert Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2014 11 Concert Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 12 Concert Pharmaceuticals, Inc. - Phase II, 2014 13 Concert Pharmaceuticals, Inc. - Phase I, 2014 14 Concert Pharmaceuticals, Inc. - Preclinical, 2014 15 Concert Pharmaceuticals, Inc. - Discovery, 2014 16 Concert Pharmaceuticals, Inc. - Pipeline by Target, 2014 25 Concert Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 26 Concert Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 27 Concert Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 28 Concert Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 29 Concert Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 33
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.